Evidence map›Paper›PMID 40140088›Full record

ArticleVirchows Archiv : an international journal of pathology2025

Gastrointestinal pathology in Good's syndrome, thinking beyond common variable immunodeficiency: a clinicopathological observation.

Pooja Navale, Ofer Zimmerman, James Wedner, Anupam Pande, Samuel Ballentine

Abstract readCase Reports
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Pooja NavaleDepartment of Pathology, Cooper University Health Care, 1 Cooper Plaza, Pavilion Building P065, Camden, NJ, 08103, USA. navale-pooja@cooperhealth.edu.ORCID http://orcid.org/0000-0002-6693-1989
Ofer ZimmermanDepartment of Medicine, Washington University in St Louis, St Louis, MO, USA.
James WednerDepartment of Medicine, Washington University in St Louis, St Louis, MO, USA.
Anupam PandeDepartment of Medicine, Washington University in St Louis, St Louis, MO, USA.
Samuel BallentineDepartment of Pathology, Washington University in St Louis, St Louis, MO, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Good's syndrome (GS) is a rare immunodeficiency associated with thymoma, characterized by increased susceptibility to bacterial, viral, and fungal infections, along with autoimmune manifestations. Gastrointestinal symptoms are common in GS, yet its clinical and histopathological features remain underrecognized. Due to significant overlap in clinical presentation and immunological profiles, GS is frequently misdiagnosed as common variable immunodeficiency (CVID). While gastrointestinal pathology in CVID has been well-documented, data on gastrointestinal manifestations in GS are limited. In this study, we analyzed two cases of GS, both demonstrating marked reduction of plasma cells across multiple gastrointestinal sites, with variable intraepithelial lymphocytosis and mild to moderate villous blunting in the duodenum and features secondary to chronic norovirus infection in one case, and an invasive adenocarcinoma with notable depletion of lamina propria plasma cells in the other. Accurate recognition of GS is essential for pathologists and clinicians, given its poorer prognosis compared to CVID.

Indexed as

AdenocarcinomaCommon Variable ImmunodeficiencyThymomaThymus NeoplasmsAdultAgedDiagnosis, DifferentialFemaleHumansLymphocytosisMaleMiddle AgedPlasma CellsCVIDGastrointestinal biopsyGood’s syndromeImmunodeficiency

Identifiers

PMID40140088
PMCPMC12647230

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.